Moonlake Immunotherapeutics (MLTX)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Insider Trading Sentiment: Reduce

Sentiment Breakdown by Insider

0

(3)

0

(2)

5

(1)

2

0

0

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
08-Oct-24 6:50 PM View:	04-Oct-24 Private Sale ($100.00M)	Bvf Partners L P/il Director 10% Owner		Moonlake Immunotherapeutics - MLTX	(9%) 21.69M to 19.69M	0	0	--	--	Show Txns Hide Txns

21-Dec-23 4:01 PM View:	20-Dec-23 Sale (Planned) ($307.10K)	Bodenstedt Matthias Chief Financial Officer		Moonlake Immunotherapeutics - MLTX	(16%) 620.9K to 520.9K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 7:53 PM View:	28-Feb-24 Sale (Planned) ($1.54M)	Reich Kristian Chief Scientific Officer		Moonlake Immunotherapeutics - MLTX	(6%) 3.17M to 2.97M	0	0	--	--	Show Txns Hide Txns

29-Feb-24 7:56 PM View:	29-Feb-24 Sale (Planned) ($264.92K)	Santos da Silva Jorge Chief Executive Officer Director		Moonlake Immunotherapeutics - MLTX	(6%) 3.17M to 2.98M	0	0	--	--	Show Txns Hide Txns

08-Oct-24 4:01 PM View:	04-Oct-24 Private Sale ($9.19M)	Sturge Simon Director		Moonlake Immunotherapeutics - MLTX	(50%) 342.98K to 171.98K	0	0	--	--	Show Txns Hide Txns